These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 2874214)

  • 1. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of etintidine, a new histamine H2-receptor antagonist.
    Scott CK; Katz LB; Shriver DA
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):5-21. PubMed ID: 2875695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
    Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
    Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441).
    Torchiana ML; Pendleton RG; Cook PG; Hanson CA; Clineschmidt BV
    J Pharmacol Exp Ther; 1983 Mar; 224(3):514-9. PubMed ID: 6131118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
    Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastric acid secretion by H2-receptor antagonists.
    Nielsen ST
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
    Poli E; Medici D; Contini GA; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
    Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
    Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.